Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma

Improta, G; Zupa, A; Natalicchio, MI; Sisinni, L; Marinaccio, A; Bozza, G; Vita, G; Aieta, M; Landriscina, M

Landriscina, M (reprint author), IRCCS, Referral Canc Ctr Basilicata, Lab Preclin & Translat Res, Via Padre Pio 1, I-85028 Rionero In Vulture, PZ, Italy.; Landriscina, M (reprint author), Univ Foggia, Med Oncol Unit, Dept Med & Surg Sci, Viale Pinto 1, I-

MEDICAL ONCOLOGY, 2018; 35 (3):

Abstract

Exons 19-21 EGFR activating mutations are predictive biomarkers of response to EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (N......

Full Text Link